Rutgers Molecular Design and Synthesis provides medicinal chemistry services, synthesis support and molecular probes for researchers at Rutgers and industry. Our core staff utilizes their vast experience to create new compounds and drive discoveries.
Under the leadership of senior vice president for research, Michael E. Zwick, PhD, the Office for Research is committed to assisting all researchers with the advanced tools and expertise they need, serving as a unifying force multiplier for the research community.
Rutgers startup Zena Therapeutics strives to create narcotic medications that will minimize or even eliminate overdoses from prescription drugs.
Key findings in the report highlight the persistence of disparities in tobacco use by race and ethnicity, level of income, level of education, gender identity, type of occupation, geography, and behavioral health status.